{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:12:59Z","timestamp":1778659979014,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Neurodegenerative diseases like Alzheimer's disease (AD), Parkinson's disease (PD),\nAmyotrophic Lateral Sclerosis (ALS), and Huntington's disease (HD) are a growing health burden\nacross the world because of the progressive loss of brain cells and the ineffective nature of the\navailable treatment. One significant challenge in the treatment of these conditions is the Blood-\n-Brain Barrier (BBB), a highly selective interface that limits the access of most therapeutic\nmolecules to the central nervous system. Nanotechnology has become an attractive approach to addressing this difficulty, as it enables the delivery of drugs with high accuracy and actively engages\nin the repair of the BBB. This review provides an overall synthesis of focused nanotechnology solutions aimed at both circumventing and restoring BBB function in neurodegenerative illnesses. It\ndiscusses various nanoparticle (NP) platforms such as polymeric, lipid-based, micellar, metallic,\nand carbon-derived systems in the light of their physicochemical aspects, transport across the\nBBB, and therapeutic efficacy. Particular emphasis is put on the receptor-mediated transcytosis,\nneurovascular unit modulations, and the regulation of Wnt, Shh, and Tie-2 signalling pathways,\nwhich are BBB integrity pathways. The review incorporates mechanisms of BBB repair in combination with neuroprotective nanotherapies, rather than focusing solely on end repair. This review\ncovers the role of targeted nanotechnology in the future of therapeutic approaches for neurodegenerative diseases. By connecting materials science, molecular neuroscience, and clinical innovation, it demonstrates how next-generation brain-targeted therapies can be developed using targeted\nnanotechnology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715273444679260416064255","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:49:01Z","timestamp":1778658541000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted Nanotechnology Approaches to Bypass the Blood\u2013brain Barrier\nin Neurodegenerative Disorders"],"prefix":"10.2174","volume":"25","author":[{"given":"Jayasurya","family":"Ramesh","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and ResearchInstitute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Jayanthi","sequence":"additional","affiliation":[{"name":"Department ofPharmacology, Karpaga Vinayaga Institute for Pharmaceutical Sciences, Chinnakolambakkam, Chengalpattu,603308, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasanth Kumar","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, School of Pharmacy, Takshashila University, Ongur,Tindivanam, 604305, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, East Point College of Pharmacy, Bengaluru,560049, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M K","family":"Vijayalakshmi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bharath Institute ofHigher Education and Research, Selaiyur, Chennai, 600073, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magesh","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of PharmaceuticalChemistry, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS),Thandalam, Chennai, 602105, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715273444679260416064255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253633\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715273444679260416064255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:49:12Z","timestamp":1778658552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253633\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715273444679260416064255","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}